Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safinamide for Pain in Parkinson's Disease
NCT07761936Phase 3Recruiting
- Sponsor
- Università degli Studi di Verona
- Start
- Apr 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 3 trial of safinamide in Parkinson's disease (PD), pain, sponsored by Università degli Studi di Verona. Started Apr 2026; status: recruiting.
02
Drugs
safinamide
03
Conditions
Parkinson's disease (PD)pain
Beyond the preview
Go deeper on NCT07761936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07761936.